PI3K/Akt: getting it right matters

被引:0
|
作者
T F Franke
机构
[1] New York University School of Medicine,Departments of Psychiatry and Pharmacology
来源
Oncogene | 2008年 / 27卷
关键词
Akt/PKB; PI3K/PTEN; PDK2; mTORC; Akt-interacting proteins; human disease;
D O I
暂无
中图分类号
学科分类号
摘要
The Akt serine/threonine kinase (also called protein kinase B) has emerged as a critical signaling molecule within eukaryotic cells. Significant progress has been made in clarifying its regulation by upstream kinases and identifying downstream mechanisms that mediate its effects in cells and contribute to signaling specificity. Here, we provide an overview of present advances in the field regarding the function of Akt in physiological and pathological cell function within a more generalized framework of Akt signal transduction. An emphasis is placed on the involvement of Akt in human diseases ranging from cancer to metabolic dysfunction and mental disease.
引用
收藏
页码:6473 / 6488
页数:15
相关论文
共 50 条
  • [1] PI3K/Akt: getting it right matters
    Franke, T. F.
    ONCOGENE, 2008, 27 (50) : 6473 - 6488
  • [2] PI3K/Akt and apoptosis: size matters
    Thomas F Franke
    Christoph P Hornik
    Lisa Segev
    Grigoriy A Shostak
    Chizuru Sugimoto
    Oncogene, 2003, 22 : 8983 - 8998
  • [3] PI3K/Akt and apoptosis: size matters
    Franke, TF
    Hornik, CP
    Segev, L
    Shostak, GA
    Sugimoto, C
    ONCOGENE, 2003, 22 (56) : 8983 - 8998
  • [4] Getting the Akt Together: Guiding Intracellular Akt Activity by PI3K
    Yudushkin, Ivan
    BIOMOLECULES, 2019, 9 (02):
  • [5] PI3K/AKT/mTOR
    Umemura, Shigeki
    Goto, Koichi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S116 - S117
  • [6] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [7] PI3K/Akt signaling in osteosarcoma
    Zhang, Jian
    Yu, Xiao-Hua
    Yan, Yi-Guo
    Wang, Cheng
    Wang, Wen-Jun
    CLINICA CHIMICA ACTA, 2015, 444 : 182 - 192
  • [8] The development of inhibitors of PI3K and Akt
    Dennis, PA
    ANNALS OF ONCOLOGY, 2006, 17 : 24 - 24
  • [9] Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway
    Bortul, R
    Tazzari, PL
    Billi, AM
    Tabellini, G
    Mantovani, I
    Cappellini, A
    Grafone, T
    Martinelli, G
    Conte, R
    Martelli, AM
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (05) : 677 - 686
  • [10] PI3K/Akt Pathway Mutations in Retinoblastoma
    Cohen, Yoram
    Merhavi-Shoham, Efrat
    Avraham-Lubin, Bat Chen R.
    Savetsky, Michael
    Frenkel, Shahar
    Pe'er, Jacob
    Goldenberg-Cohen, Nitza
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (11) : 5054 - 5056